Page last updated: 2024-11-01

nifedipine and Lupus Erythematosus, Cutaneous, Subacute

nifedipine has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 2 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kwong, HL1
Teo, RY1
Hedrich, CM1
Fiebig, B1
Hauck, FH1
Sallmann, S1
Hahn, G1
Pfeiffer, C1
Heubner, G1
Lee-Kirsch, MA1
Gahr, M1

Reviews

1 review available for nifedipine and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
Chilblain lupus erythematosus--a review of literature.
    Clinical rheumatology, 2008, Volume: 27, Issue:8

    Topics: Administration, Topical; Adolescent; Calcium Channel Blockers; Chilblains; Exodeoxyribonucleases; Ge

2008

Other Studies

1 other study available for nifedipine and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
An uncommon cutaneous reaction for a common drug. Diagnosis: Drug-induced subacute cutaneous lupus erythematosus (DI-SCLE).
    Annals of the Academy of Medicine, Singapore, 2014, Volume: 43, Issue:8

    Topics: Aged; Drug Eruptions; Female; Humans; Lupus Erythematosus, Cutaneous; Nifedipine; Vasodilator Agents

2014